EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   1.1.2.2 | Adenocarcinoma |
21964981 |
MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma. |
causal interaction
diagnostic usage
unassigned |
4
4
0 |
| 1.1.2.2 | Adenocarcinoma |
23595222 |
Metadherin confers chemoresistance of cervical cancer cells by inducing autophagy and activating ERK/NF-?B pathway. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
2
4
4
0 |
| 1.1.2.2 | Adenocarcinoma |
29908229 |
MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH. |
causal interaction
therapeutic application
unassigned |
4
3
0 |
| 1.1.2.2 | Adenoma |
25944465 |
Downregulation of miR-375 in aldosterone-producing adenomas promotes tumour cell growth via MTDH. |
unassigned |
0 |
| 1.1.2.2 | Brain Diseases |
33440655 |
AEG-1 Regulates TWIK-1 Expression as an RNA-Binding Protein in Astrocytes. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
| 1.1.2.2 | Breast Neoplasms |
19111877 |
MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 1.1.2.2 | Breast Neoplasms |
20565850 |
Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
4
1 |
| 1.1.2.2 | Breast Neoplasms |
20952513 |
Pathologically Decreased MiR-26a Antagonizes Apoptosis and Facilitates Carcinogenesis by targeting MTDH and EZH2 in Breast Cancer. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
2
1
0 |
| 1.1.2.2 | Breast Neoplasms |
21371176 |
Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
1
2 |
| 1.1.2.2 | Breast Neoplasms |
21408129 |
Identification of novel variants of metadherin in breast cancer. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
3
4
0 |
